No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 1065-1079

  Blennow, K ^a,b   Ricksten, A ^a   Prince, J A ^c   Brookes, A J ^c   Emahazion, T ^c   Wasslavik, C ^a   Bogdanovic, N ^d   Andreasen, N ^e   Batsman S ^f   Marcusson, J ^g   Nagga K ^g   Wallin, A ^a   Regland, B ^a   Olofsson, H ^a   Hesse, C ^a   Davidsson, P ^a   Minthon, L ^h   Jansson, A ^a   Palmqvist, L ^a   Rymo, L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Medical Research Council   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Pitea River Valley Hospital   (Sweden)

^f Kalix General Medical Center   (Sweden)

^g LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Apolipoprotein E (apoE); Senile plaques

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; MESSENGER RNA; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DEGENERATIVE DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CAUCASIAN; CEREBROSPINAL FLUID; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; SENILE PLAQUE; WESTERN BLOTTING;

AGED; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BASE SEQUENCE; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENILE PLAQUES; SEQUENCE ANALYSIS, DNA;

EID: 0033626319     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070052     Document Type: Article

References (46)

1. Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis
2. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
3. Protective effect of apoE epsilon 2 in Alzheimer's disease
4. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
5. In reply
6. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
7. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region
8. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
9. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
10. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
11. Rapid detection of a pentanucleotide deletion polymorphism in the human alpha2-macroglobulin gene
12. α-2 Macroglobulin polymorphism and Alzheimer disease risk in the UK
13. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons
14. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician
15. Clinical-neuropathological correlations in Alzheimer's disease and related dementias
16. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism
17. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
18. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study
19. Amyloid plaque core protein in Alzheimer's disease and Down syndrome
20. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene
21. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease
22. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease
23. ApoE genotype predicts when - Not whether - One is predisposed to develop Alzheimer's disease
24. The consortium to establish a registry for Alzheimer's Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer's disease
25. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein
26. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
27. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
28. Apolipoprotein E polymorphism and Alzheimer's disease
29. Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex
30. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein
31. An -2-macroglobulin insertion-deletion polymorphism in Alzheimer disease
32. Apolipoprotein E alleles as risk factors in Alzheimer's disease
33. α-2 Macroglobulin gene and Alzheimer disease
34. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease
35. Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing
36. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease
37. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
38. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease
39. Hypothesis: Microtubule instability and paired helical filaments formation in the Alzheimer's disease brain are related to apolipoprotein E genotype
40. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing
41. Protection against Alzheimer's disease with apoE epsilon 2
42. The gene defects responsible for familial Alzheimer's disease
43. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
44. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival
45. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease
46. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease